secwatch.observer — SEC 8-K summary
======================================

Issuer:     INSULET CORP (PODD)
CIK:        0001145197
Form:       8-K
Filed at:   2023-06-07T23:59:59+00:00
Accession:  0001145197-23-000047
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Insulet extends Amgen supply agreement through 2028, adds IP license
--------------------------------------------------------------------

- Amendment 21 extends term to December 31, 2028; parties to negotiate renewal by Jan 1, 2027.
- Insulet and Amgen entered a Patent Assignment and License Agreement for IP rights.
- New manufacturing site(s) added; Insulet responsible for equipment/labor to maintain quality.
- Minimum purchase commitments revised but specific amounts redacted.
- Payment terms amended; Safety Agreement terminated.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1145197/000114519723000047/0001145197-23-000047-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1145197/000114519723000047/podd-20230601.htm
  HTML page:      https://secwatch.observer/filing/0001145197-23-000047

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer